OMX Stockholm 30
2.544,04
PKT
+1,72
PKT
+0,07
%
Werbung
Analysen zu OMX Stockholm 30-Werten
Datum | Rating | Analyst | |
---|---|---|---|
24.10.17 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
24.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
24.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
23.10.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
23.10.17 | AstraZeneca Neutral | UBS AG | |
23.10.17 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
23.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
23.10.17 | Volvo (B) buy | Citigroup Corp. | |
20.10.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
20.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
20.10.17 | Volvo (B) buy | S&P Capital IQ | |
20.10.17 | Volvo (B) Neutral | UBS AG | |
20.10.17 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
19.10.17 | Volvo (B) buy | HSBC | |
18.10.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
17.10.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
17.10.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
17.10.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
17.10.17 | Volvo (B) Neutral | UBS AG | |
16.10.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
16.10.17 | AstraZeneca Outperform | Credit Suisse Group | |
12.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
11.10.17 | AstraZeneca buy | Deutsche Bank AG | |
11.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
11.10.17 | ABB (Asea Brown Boveri) Hold | HSBC | |
10.10.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
09.10.17 | Volvo (B) Underweight | Morgan Stanley | |
09.10.17 | AstraZeneca Neutral | UBS AG | |
09.10.17 | AstraZeneca Reduce | HSBC | |
05.10.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
03.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Credit Suisse Group | |
02.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
26.09.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
26.09.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
26.09.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
25.09.17 | AstraZeneca Outperform | BNP PARIBAS | |
25.09.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
22.09.17 | AstraZeneca Outperform | Bernstein Research | |
19.09.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
18.09.17 | AstraZeneca Hold | Jefferies & Company Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.